Annual report pursuant to Section 13 and 15(d)

Agreement Related to Intellectual Property Right (Details Narrative)

v3.19.1
Agreement Related to Intellectual Property Right (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
May 12, 2018
Jun. 30, 2018
Dec. 31, 2018
Dec. 31, 2017
Nov. 30, 2016
Lucid Diagnostics Inc [Member]          
Shares of common stock percentage     81.875%    
Contract Development and Manufacturing Organization [Member]          
Number of units to purchase order   $ 5,000      
Payment to third-party   $ 50,000      
EsoCheck License Agreement[Member] | Research and Development Expense [Member]          
Reimbursement of patent fees     $ 20,978    
EsoCheck License Agreement[Member] | Lucid Diagnostics Inc [Member]          
Reimbursement amount $ 273,000        
License fee as an initial requirement 50,000        
Initial payment of intellectual property $ 50,000        
Description of intellectual property payment quarterly payments of $50,000 until such fee is paid-in-full, provided, however, the commencement of such quarterly payments is subject to Lucid Diagnostics Inc. consummation of a bona fide financing with an unrelated third-party in excess of $500,000.        
Description of equity interest percentage The right, in its sole discretion, to require the Company to transfer to CWRU a percentage, varying up to 100%, of the shares of common stock of Lucid Diagnostics Inc.        
Shares of common stock percentage 100.00%        
Consulting Agreements [Member] | 2014 Long-Term Incentive Plan [Member] | Parent Company [Member]          
Purchase shares of common stock 25,000        
Exercise price per share of common stock $ 1.59        
Consulting Agreements [Member] | Lucid Diagnostics Inc [Member] | 2018 Long-Term Incentive Equity Plan [Member]          
Purchase shares of common stock 100,000        
Exercise price per share of common stock $ 0.50        
Consulting Agreements [Member] | Contract Development and Manufacturing Organization [Member]          
Purchase shares of common stock   75,000      
Exercise price per share of common stock   $ 1.00      
Tufts Patent License Agreement [Member]          
Non-refundable fees         $ 50,000
Tufts Patent License Agreement [Member] | Research and Development Expense [Member]          
Reimbursement of patent fees     $ 113,688 $ 67,501